The risk of cardiovascular disease in adults who have had childhood nephrotic syndrome

被引:39
作者
Lechner, BL [1 ]
Bockenhauer, D [1 ]
Iragorri, S [1 ]
Kennedy, TL [1 ]
Siegel, NJ [1 ]
机构
[1] Yale Univ, Sch Med, Dept Pediat, Div Pediat Nephrol, New Haven, CT 06510 USA
关键词
nephrosis; hyperlipidemia; cholesterol-lowering agents; corticosteroids; myocardial infarction;
D O I
10.1007/s00467-004-1460-x
中图分类号
R72 [儿科学];
学科分类号
100202 ;
摘要
While increased risk of cardiovascular disease (CVD) in patients with hyperlipidemia, chronic kidney disease (CKD), or end-stage renal disease (ESRD) is well documented, transient hyperlipidemia or intermittent renal disease as a consequence of relapsing nephrotic syndrome (NS) has not been studied. To investigate this enigma, 62 patients, between 25 and 53 years of age, who had steroid-responsive/dependent NS during childhood, were identified from the records of the Division of Pediatric Nephrology at Yale School of Medicine. Forty patients were located and contacted to ascertain symptoms or occurrences of CVD via a telephone interview. At the time of follow-up, 23-46 years after cessation of NS, none of these patients had ESRD or CKD. Three patients had experienced a myocardial infarction (MI): a 32-year-old male with a family history of CVD; a 41-year-old male with a history of heavy smoking, hypertension, diabetes mellitus, and elevated cholesterol; a 31-year-old male after a cocaine overdose. The occurrence of events (8%) and mortality from CVD (none) in this cohort of patients is comparable to patients of a similar age in the general population and is lower than that of patients of the same age who are on dialysis. The data suggest that relapsing NS during childhood does not place patients at increased risk for CVD mortality or morbidity compared with the general population. Consequently, it would appear that factors related to persistent proteinuria or renal insufficiency, rather than transient proteinuria and renal disease, contribute to the CVD documented in patients with CKD or ESRD.
引用
收藏
页码:744 / 748
页数:5
相关论文
共 18 条
[1]  
ABRAMOWI.M, 1970, LANCET, V1, P959
[2]   Management of minimal lesion glomerulonephritis: Evidence-based recommendations [J].
Bargman, JM .
KIDNEY INTERNATIONAL, 1999, 55 :S3-S16
[3]   STEROID-RESPONSIVE NEPHROTIC SYNDROME OF CHILDHOOD - A LONG-TERM STUDY OF CLINICAL COURSE, HISTOPATHOLOGY, EFFICACY OF CYCLOPHOSPHAMIDE THERAPY, AND EFFECTS ON GROWTH [J].
BERNS, JS ;
GAUDIO, KM ;
KRASSNER, LS ;
ANDERSON, FP ;
DURANTE, D ;
MCDONALD, BM ;
SIEGEL, NJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1987, 9 (02) :108-114
[4]  
CHURG J, 1970, LANCET, V1, P1299
[5]   Cardiovascular mortality in end-stage renal disease [J].
Collins, AJ .
AMERICAN JOURNAL OF THE MEDICAL SCIENCES, 2003, 325 (04) :163-167
[6]   NEPHROSIS - A LONG-TERM STUDY OF CHILDREN TREATED WITH CORTICOSTEROIDS [J].
CORNFELD, D ;
SCHWARTZ, MW .
JOURNAL OF PEDIATRICS, 1966, 68 (04) :507-+
[7]   Steroid-sensitive nephrotic syndrome:: From childhood to adulthood [J].
Fakhouri, F ;
Bocquet, N ;
Taupin, P ;
Presne, C ;
Gagnadoux, MF ;
Landais, P ;
Lesavre, P ;
Chauveau, D ;
Knebelmann, B ;
Broyer, M ;
Grünfeld, JP ;
Niaudet, P .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2003, 41 (03) :550-557
[8]   Possible induction of renal dysfunction in patients with lecithin:cholesterol acyltransferase deficiency by oxidized phosphatidylcholine in glomeruli [J].
Jimi, S ;
Uesugi, N ;
Saku, K ;
Itabe, H ;
Zhang, B ;
Arakawa, K ;
Takebayashi, S .
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 1999, 19 (03) :794-801
[9]  
*NAT CTR HLTH STAT, 2003, SUMM STAT US CHILDR
[10]  
*NAT I DIAB DIG KI, 2000, US REN DAT SYST ANN